This system allows for the study of the interaction between tumor-infiltrating T cells (TILs) and tumor cells under physiologically relevant conditions, representing a significant advancement in the evaluation of immunotherapies such as PD-1/PD-L1 blockade. The gene discussed is CD274; the disease is neoplasm.